indē wild, the Indian-born beauty label founded by entrepreneur and influencer Diipa Büller-Khosla, is rewriting the global skincare narrative with its distinctive approach, a blend of Ayurvedic tradition and modern science. Launched in mid-2022, the brand has grown exponentially, both in revenue and reach.

In its very first year, indē wild generated $1.9 million in sales, with momentum surging following the success of its now-iconic Champi Hair Oil. By the end of 2024, monthly revenues touched $730,000, supported by its entry into Sephora UK and sustained double-digit contribution margins. The brand posted $4.94 million in sales in the first half of 2025 alone. With fresh launches and wider North American expansion in the pipeline, it is on track to cross $12 million this year, marking a ₹100 crore topline milestone within four years of inception.

indē wild has bold ambitions to reach a $120 million annual run rate by 2028, positioning itself as the first global beauty powerhouse from India.

Diipa Büller-Khosla explained that her vision was to create a beauty label rooted in Indian heritage but with global appeal. The initial traction of $500,000 in the first quarter proved there was an appetite for authentic, high-performance Indian skincare. Today, viral products like the Dewy Lip Treatment and AM Vitamin C Serum have solidified the brand’s international following.

The Dewy Lip Treatment even proved expedition-worthy, accompanying vegan mountaineer Prakriti Varshney on her 40-day Lhotse climb. She credited it as the only balm that withstood extreme weather at 8,000 metres.

Backed by $8 million in funding from SoGal Ventures and Unilever Ventures, the brand has secured leading positions on platforms like Nykaa and Tira. It has become the first Indian label stocked in Sephora UK. A Sephora US launch is scheduled for 2026.

As Ayurveda gains global traction with the $8 billion market projected to grow over 28% annually, indē wild is perfectly positioned to lead this shift with its science-backed, purpose-driven formulations.